10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-036542`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	rlmd-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 44 Cash Flow Statement 62 Stockholders Equity 46

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents	`CashEquivalentsAtCarryingValue`	$7.54M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$115.59M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$80.16M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$73.09K	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$77.81K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.25M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$423.86K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.46M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$125.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$116.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.46M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$5.01K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.19M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.08K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$165.83K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$106.87K	USD	Point-in-time
Total assets	`Assets`	$117.14M	USD	Point-in-time
Total assets	`Assets`	$125.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$728.63K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$522.66K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$824.94K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.66M	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$110.25K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.39M	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 16,189,258 and 14,457,013 shares issued and outstanding, respectively	`CommonStockValue`	$16.19K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 16,189,258 and 14,457,013 shares issued and outstanding, respectively	`CommonStockValue`	$14.46K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$280.75M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$235.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-158.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-119.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$113.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$5.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$122.21M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$473.90K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$115.68M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.61M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$132.23M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$125.60M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$117.14M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$21.07M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.89M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$11.24M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.23M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.82M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.31M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$18.85M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$10.55M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$17.18M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$39.92M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-10.55M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-17.18M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-39.92M	USD	3 Qtrs
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$1.17M	USD	3 Qtrs
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$37.92K	USD	1 Quarter
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$363.30K	USD	1 Quarter
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$66.97K	USD	3 Qtrs
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	$86.17K	USD	1 Quarter
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	$244.97K	USD	3 Qtrs
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	-	USD	1 Quarter
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	-	USD	3 Qtrs
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	-	USD	1 Quarter
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	$-3.95K	USD	1 Quarter
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	-	USD	3 Qtrs
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	$-290.97K	USD	3 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$37.92K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$281.07K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$66.97K	USD	3 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$1.22M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-38.69M	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.23	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-2.52	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.05	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.76M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	16.04M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.37M	shares	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.52M	shares	3 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-38.69M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$3.26K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$2.93K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$17.59M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.56M	USD	3 Qtrs
Fair value of shares relinquished in litigation	`FairValueOfSharesRelinquished`	-	USD	3 Qtrs
Fair value of shares relinquished in litigation	`FairValueOfSharesRelinquished`	$-394.41K	USD	3 Qtrs
Realized loss on short-term investments	`IncreaseDecreaseRealizedLossOnShorttermInvestments`	$244.97K	USD	3 Qtrs
Realized loss on short-term investments	`IncreaseDecreaseRealizedLossOnShorttermInvestments`	-	USD	3 Qtrs
Unrealized gain on short-term investments	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Unrealized gain on short-term investments	`UnrealizedGainLossOnDerivatives`	$290.97K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$6.09K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-49.90K	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-54.24K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-524.97K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.83M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$907.66K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$205.97K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-376.16K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.21M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.88M	USD	3 Qtrs
Purchase of short-term investments	`PurchaseOfShorttermInvestments`	-	USD	3 Qtrs
Purchase of short-term investments	`PurchaseOfShorttermInvestments`	$88.76M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$53.38M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-35.38M	USD	3 Qtrs
Principal payments of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-110.25K	USD	3 Qtrs
Principal payments of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-223.02K	USD	3 Qtrs
Proceeds from issuance of common stock - net	`ProceedsFromIssuanceOfCommonStock`	$13.41M	USD	3 Qtrs
Proceeds from issuance of common stock - net	`ProceedsFromIssuanceOfCommonStock`	$19.82M	USD	3 Qtrs
Proceeds from options exercised for common stock	`OptionsExercisedForCommonStock`	$636.52K	USD	3 Qtrs
Proceeds from options exercised for common stock	`OptionsExercisedForCommonStock`	-	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$450.00K	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$7.19M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.53M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.64M	USD	3 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.42M	USD	3 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-28.73M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.85M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.54M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.85M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.54M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Interest	`InterestPaidNet`	$6.96K	USD	3 Qtrs
Interest	`InterestPaidNet`	$2.42K	USD	3 Qtrs
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$43.00	USD	3 Qtrs
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$25.00	USD	3 Qtrs
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	$90.00	USD	3 Qtrs
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	-	USD	3 Qtrs
Notes payable issued in connection with directors and officers insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$364.20K	USD	3 Qtrs
Notes payable issued in connection with directors and officers insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	-	USD	3 Qtrs

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$122.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$473.90K	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.43M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$7.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.04M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$394.69K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.24M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$757.72K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$403.46K	USD	1 Quarter
Purchase of common stock	`PurchaseOfCommonStock`	$825.75K	USD	1 Quarter
Warrants exercised	`WarrantsExercised`	$450.00K	USD	1 Quarter
Equity units issued for Cash	`StockIssuedDuringPeriodValueOther`	$1.73M	USD	1 Quarter
Equity units issued for Cash	`StockIssuedDuringPeriodValueOther`	$10.86M	USD	1 Quarter
Shares relinquished	`StockIssuedDuringPeriodSharesRelinquished`	$-394.41K	USD	1 Quarter
Warrant exercised for cash	`ProceedsFromWarrantExercises`	$2.58M	USD	1 Quarter
Warrant exercised for cash	`ProceedsFromWarrantExercises`	$3.04M	USD	1 Quarter
Warrant exercised for cash	`ProceedsFromWarrantExercises`	$1.57M	USD	1 Quarter
Warrant exercised for cash	`ProceedsFromWarrantExercises`	$7.19M	USD	3 Qtrs
Cashless warrant exercise	`StockIssuedDuringCashlessWarrantExercise`	-	USD	1 Quarter
Cashless warrant exercise	`StockIssuedDuringCashlessWarrantExercise`	-	USD	1 Quarter
Cashless warrant exercise	`StockIssuedDuringCashlessWarrantExercise`	-	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$457.62K	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$105.88K	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.02K	USD	1 Quarter
Cashless option exercised	`CashlessOptionExercised`	-	USD	1 Quarter
Equity offering, costs (net)	`ATMOfferingFees`	$19.86M	USD	1 Quarter
Equity offering, costs (net)	`ATMOfferingFees`	$-38.42K	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-16.90M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.69M	USD	1 Quarter
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$122.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$473.90K	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.43M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.